In an animal model in diabetes research, CLU expression decreased the levels of pro-inflammatory cytokines, including intercellular adhesion molecule 1 (ICAM1) and vascular cell adhesion protein 1 (VCAM1), and reduced the mitochondrial production of ROS, ameliorating vascular complications associated with diabetes [91]. The gene discussed is CLU; the disease is diabetes mellitus.